ORAL CANCER: LYMPHO DISSECTION AT CN0 AND CN+ door Sh. I. Musin

Volledige tekst

PERIOPERATIVE ASSESSMENT OF CHEMILUMINESCENCE INDICATORS OF LYMPH NODES IN TONGUE CANCER door Sh. I. Musin, R. R. Farkhutdinov

Volledige tekst

Predictors of Multiple Primary Malignancies: Literature Review door A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva

Volledige tekst

Features of the Course of Radioinduced Breast Cancer. Clinical Observation door M. M. Zamilov, K. V. Menshikov, Sh. I. Musin, A. V. Sultanbaev, G. I. Zamilova, A. H. Nguyen

Volledige tekst

Hedgehog inhibitor in the treatment of basal cell skin cancer: case report door Sh. I. Musin, N. А. Sharafutdinova, A. V. Sultanbaev, S. V. Osokin, B. A. Ibragimov, K. V. Menshikov, R. T. Ayupov

Volledige tekst

Clinical case of the treatment of metastatic luminal breast cancer door A. F. Nasretdinov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, A. A. Izmailov, R. T. Ayupov

Volledige tekst

A biopsy of the signaling lymph node in case of early oral cancer (cT1–2N0M0) by the lymphoscintigraphic method: one center study door Sh. I. Musin, S. V. Osokin, Т. G. Yatsenko, A. V. Sultanbaev, М. М. Zamilov, М. М. Vakhito, V. V. Ilyin

Volledige tekst

Eribulin in Metastatic Breast Cancer: Actual Clinical Practice door A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, V. E. Askarov

Volledige tekst

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer door A. F. Nasretdinov, N. I. Sultanbaeva, Sh. I. Musin, A. V. Pushkarev, K. V. Menshikov, V. A. Pushkarev, A. V. Sultanbaev

Volledige tekst

Neuroendocrine Tumours: a Literature Review door K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, I. R. Shaykhutdinov

Volledige tekst

Combined Use of Cabozantinib and Nivolumab in Clinical Practice door V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, E. V. Popova, I. A. Menshikova

Volledige tekst

Metastatic renal cell carcinoma, the possibility of targeted therapy. Case. door K. V. Menshikov, A. A. Izmailov, A. V. Sultanbaev, Sh. I. Musin, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov

Volledige tekst

Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency door R. T. Ayupov, A. A. Izmailov, K. V. Menshikov, A. V. Sultanbaev, A. F. Nasretdinov, R. R. Rakhimov, Sh. I. Musin, N. I. Sultanbaeva

Volledige tekst

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review) door K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, O. N. Lipatov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova

Volledige tekst

Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review door K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, L. A. Khammatova

Volledige tekst

Atezolizumab and Bevacizumab in Therapy for Patients with Hepatocellular Carcinoma in Real Clinical Practice door G. A. Serebrennikov, К. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov, A. Sh. Rezyapova

Volledige tekst

Immunotherapy of advanced hepatocellular carcinoma: case report and literature review door K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, R. R. Abdeev, N. I. Sultanbaeva, V. G. Nigmatullin, E. V. Popova

Volledige tekst

Efficacy of the 1^st generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens door K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, D. O. Lipatov

Volledige tekst

Surgical stage in sequential therapy of unresectable oral cancer T3-4bN0-3M0: evaluation of treatment results door Sh. I. Musin, A. V. Sultanbayev, K. V. Menshikov, F. F. Mufazalov, A. F. Nasretdinov, O. V. Goncharova, S. V. Osokin, M. M. Zamilov, K. E. Timin

Volledige tekst

Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case door A. V. Sultanbaev, Sh. I. Musin, K. V. Menshikov, A. F. Nasretdinov, B. A. Ibragimov, A. G. Nigmatullin, R. T. Ayupov, A. A. Izmailov, N. I. Sultanbaeva

Volledige tekst